Publications

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Bachoud-Levi, A., Déglon, N., Nguyen, J., Bloch, J., Bourdet, C., Winkel, L., Remy, P., Goddard, M., Lefaucheur, J., Brugières, P., Baudic, S., Cesaro, P., Peschanski, M. & Aebischer, P. (2000). Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Human Gene Therapy, 11(12), 1723-1729. doi:10.1089/10430340050111377

Bachoud-Levi, A., Remy, P., Nguyen, J., Brugières, P., Lefaucheur, J., Bourdet, C., Baudic, S., Gaura, V., Maison, P., Haddad , B., Boissé, M., Grandmougin , T., Jény , R., Bartolomeo, P., Barba, G., Degos, J., Lisovoski , F., Ergis, A., Pailhous , E., Cesaro, P., Hantraye, P. & Peschanski, M. (2000). Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet, 356(9246), 1975-1979. doi:10.1016/S0140-6736(00)03310-9

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E. & Registry Investigators Of The European Huntington'S Disease, N. (2013). β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease. Journal of Huntington's disease. doi:10.3233/jhd-130002

Orth, M., European Huntington'S Disease, N., Handley, O., Schwenke, C., Dunnett, S., Wild, E., Tabrizi, S. & Landwehrmeyer, G. (2011). Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. Journal of Neurology, Neurosurgery, and Psychiatry. doi:10.1136/jnnp.2010.209668

Wetzel, H., Gehl, C., Dellefave-Castillo, L., Schiffman, J., Shannon, K., Paulsen, J. & Huntington Study, G. (2011). Suicidal ideation in Huntington disease: the role of comorbidity. Psychiatry research. doi:10.1016/j.psychres.2011.05.006

Maison, P., Saleh, N. & Bachoud-Levi, A. (2011). Reply from the authors. Neurology, 76(7). doi:10.1212/WNL.0b013e3181fe74ba

Anderson, K., Gehl, C., Marder, K., Beglinger, L., Paulsen, J. & Huntington'S Study, G. (2010). Comorbidities of obsessive and compulsive symptoms in Huntington's disease. The Journal of nervous and mental disease. doi:10.1097/nmd.0b013e3181da852a

Bourlon, C., Chokron, S., Bachoud-Levi, A., Coubard, O., Bergeras, I., Moulignier, A., Viret, A. & Bartolomeo, P. (2009). Presentation of an assessment battery for visual mental imagery and visual perception | Normalisation d'une batterie d'évaluation de l'imagerie mentale visuelle et de la perception visuelle. Revue Neurologique, 165(12), 1045-1054. doi:10.1016/j.neurol.2009.04.010

Aziz, N., Van Der Burg, J., Landwehrmeyer, G., Brundin, P., Stijnen, T., Ehdi Study, G. & Roos, R. (2008). Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. doi:10.1212/01.wnl.0000334276.09729.0e

De Diego-Balaguer, R., Rodriguez-Fornells, A. & Bachoud-Levi, A. (2015). Prosodic Cues Enhance Rule Learning by Changing Speech Segmentation Mechanisms . Frontiers in Psychology, 6

Callaghan, J., Stopford, C., Arran, N., Boissé, M., Coleman, A., Santos, R., Dumas, E., Hart, E., Justo, D., Owen, G., Read, J., Say, M., Durr, A., Leavitt, B., Roos, R., Tabrizi, S., Bachoud-Levi, A., Bourdet, C., Van Duijn, E. & Craufurd, D. (2015). Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies. The Journal of neuropsychiatry and clinical neurosciences, 27(1), 59-64. doi:10.1176/appi.neuropsych.13070169

Aiuti, A., Bachoud-Levi, A., Blesch, A., Brenner, M., Cattaneo, F., Chiocca, E., Gao, G., High, K., Leen, A., Lemoine, N., Mcneish, I., Meneguzzi, G., Peschanski, M. & Wilson, J. (2007). Progress and prospects: gene therapy clinical trials (part 2). Gene therapy. doi:10.1038/sj.gt.3303033

Allain, P., Gaura, V., Fasotti, L., Chauviré, V., Prundean, A., Sherer-Gagou, C., Bonneau, D., Bachoud-Levi, A., Dubas, F., Remy, P., Le Gall, D. & Verny, C. (2011). The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease. Neuropsychologia, 49(9), 2673-84. doi:10.1016/j.neuropsychologia.2011.05.015

Aoun Sebaiti, M., Kauv, P., Charles-Nelson, A., Van Der Gucht, A., Blanc-Durand, P., Itti, E., Gherardi, R., Bachoud-Levi, A. & Authier, F. (2017). Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile. Journal of inorganic biochemistry, S0162(17), 30652-9. doi:10.1016/j.jinorgbio.2017.09.019

Bachoud-Levi, A., (Et Al), . & Cleret de Langavant, L. (2020). Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Movement disorders, 35(8), 1323-1335. doi:10.1002/mds.28201

Bachoud-Levi, A., Massart, R. & Rosser, A. (2021). Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward. Stem Cells, 39(2), 144-155. doi:10.1002/stem.3300

Bachoud-Levi, A. (2020). Long before Huntington's disease: what matters most? The Lancet Neurology, 19(6), 473-475. doi:10.1016/S1474-4422(20)30156-3

Bachoud-Levi, A., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., Squitieri, F., Seppi, K., Perrine, C., Scherer-Gagou, C., Audrey, O., Verny, C. & Burgunder, J. (2019). International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology, 10, 710. doi:10.3389/fneur.2019.00710

Bachoud-Levi, A., Gaura, V., Brugières, P., Lefaucheur, J., Boissé, M., Maison, P., Baudic, S., Ribeiro, M., Bourdet, C., Remy, P., Cesaro, P., Hantraye, P. & Peschanski, M. (2006). Persistent benefit of foetal neural transplants in patients with Huntington's disease six years after surgery. Lancet Neurol(5 ), 303-309

Bachoud-Levi, A., Remy, P., Brugières, P., Lefaucheur, J., Bourdet, C., Baudic, S., Gaura, V., Maison, P., Haddad , B., Boissé, M., Grandmougin , T., Jény , R., Bartolomeo, P., Dalla Barba , G., Degos, J., Lisovoski , F., Pailhous , E., Cesaro, P., Hantraye, P. & Peschanski, M. (2000). Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet(356), 1975-1979

Bachoud-Levi, A. (2009). Neural grafts in Huntington's disease: viability after 10 years. The Lancet. Neurology, 8(11), 979-81. doi:10.1016/S1474-4422(09)70278-9

Bachoud-Levi, A., Bourdet, C., Brugières, P., Nguyen, J., Grandmougin , T., Haddad , B., Jény , R., Bartolomeo, P., Boissé, M., Barba, G., Degos, J., Ergis, A., Lefaucheur, J., Lisovoski , F., Pailhous , E., Remy, P., Palfi, S., Defer, G., Cesaro, P., Hantraye, P. & Peschanski, M. (2000). Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Experimental Neurology, 161(1), 194-202. doi:10.1006/exnr.1999.7239

Bachoud-Levi, A., Ergis, A., Cesaro, P. & Degos, J. (2000). Dissociation between distal and proximal left limb agraphia and agraphesthesia in a patient with a callosal disconnection syndrome. Cortex, 36(3), 351-363. doi:10.1016/S0010-9452(08)70846-3

Bachoud-Levi, A. & Perrier, A. (2014). Regenerative medicine in Huntington's disease: Current status on fetal grafts and prospects for the use of pluripotent stem cell. Revue Neurologique, 170(12), 749-762. doi:10.1016/j.neurol.2014.10.007

Bachoud-Levi, A., Maison, P., Bartolomeo, P., Boissé, M., Dalla Barba , G., Ergis, A., Baudic, S., Degos, J., Cesaro, P. & Peschanski, M. (2001). Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology, 56(8), 1052-1058. doi:10.1212/WNL.56.8.1052

Bachoud-Levi, A., Gaura, V., Brugières, P., Lefaucheur, J., Boissé, M., Maison, P., Baudic, S., Ribeiro, M., Bourdet, C., Remy, P., Cesaro, P., Hantraye, P. & Peschanski, M. (2006). Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. The Lancet. Neurology, 5(4), 303-9. doi:10.1016/S1474-4422(06)70381-7

Bachoud-Levi, A. & Bartolomeo, P. (2003). Mechanisms of pure alexia: spatially based impairment, letter identification deficit, or both? Neurocase, 9(2), 164-76. doi:10.1076/neur.9.2.164.15069

Bachoud-Levi, A., Hantraye, P. & Peschanski, M. (2002). Fetal neural grafts for Huntington's disease: a prospective view. Movement disorders : official journal of the Movement Disorder Society, 17(3), 439-44. doi:10.1002/mds.10117

Bachoud-Levi, A. (2017). From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies. Prog Brain Res. (Vol. 230, pp. 227-261). doi:10.1016/bs.pbr.2016.12.011